High dose rate endobronchial brachytherapy in the management of advanced lung cancer - comparison of different doses - preliminary assessment

Reports of Practical Oncology and Radiotherapy

Volumn 7, Issue 3, 2002, Pages 109-115

  Skowronek, Janusz ^a   Adamska, Krystyna ^a   Zwierzchowski, Grzegorz ^a   Piotrowski, Tomasz ^a   Cofta, Szczepan ^b   Świerkocki, Krzysztof ^b   Piorunek, Tomasz ^b   Młynarczyk, Witold ^b  

^a Great Poland Cancer Centre   (Poland)

^b POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

HDR brachytherapy; Lung cancer

Indexed keywords

EID: 68849121175     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1507-1367(02)70985-1     Document Type: Article

References (21)

1. Barber P, Stout R. High dose rate endobronchial brachytherapy for the treatment of lung cancer: current status and indications. Thorax 1996;51:345-7.
2. Delclos ME, Komaki R, Morice RC, Allen PK, Davis M, Garden A. Endobronchial brachytherapy with highdose-rate remote afterloading for recurrent endobronchial lesions. Radiology 1996; 201:279-82.
3. Stephens KE Jr, Wood DE. Bronchoscopic management of central airway obstruction. J Thorac Cardiovasc Surg 2000;119: 289-96.
4. Sutedja G, Baris G, van Zadwijk N, Postmus PE. High-dose rate brachytherapy has a curative potential in patients with intraluminal squamous cell lung cancer. Respiration 1993;61:167-8.
5. Taulelle M, Chauvet B, Vincent P, Felix-Faure C, Buciarelli B, Garcia R et al. High dose rate endobronchial brachytherapy: results and complications in 189 patients. Eur Respir J 1998;11:162-8.
6. Harms W, Schraube P, Becker H, Latz D, Herth F, Fritz P et al. Effect and toxicity of endoluminal high-dose-rate (HDR) brachytherapy in centrally located tumors of the upper respiratory tract. Strahlenther Onkol 2000;176:60-6.
7. Hilaris BS, Mastoras DA. Contemporary brachytherapy approaches in non- small cell lung cancer. Journal of Surgical Oncology 1998;69:258-64.
8. Perol M, Caliandro R, Pommier P, Malet C, Montbarbon X, Carrie C et al. Curative irradiation of limited endobronchial carcinomas with high-dose rate brachytherapy. Results of a pilot study. Chest 1997;111: 1417-23.
9. Macha HN, Freitag L. The role of brachytherapy in the treatment and control of central bronchial carcinoma. Monaldi Arch Chest Dis 1996;51:325-8.
10. Gaspar LE. Brachytherapy in lung cancer. J Surg Oncol 1998;67:60-70.
11. Makarewicz R, Czechowicz W, Terlikiewicz J. Wste{ogonek}pna ocena skuteczności paliatywnej brachyterapii u chorych na niedrobnokomórkowego raka płuca. Nowotwory 1995; 45:260-5.
12. Speiser BL. Brachytherapy in the treatment of thoracic tumors. Lung and esophageal. Hematol Oncol Clin North Am 1999;13:609-34.
13. Kasprowicz A, Łyczek J, Kulik A, Kubicka I, Dolińska H. Paliatywna jednofrakcyjna brachyterapia HDR w leczeniu zaawansowanego miejscowo raka oskrzeli. Nowotwory 1999;49:35-8.
14. Dosoretz DE, Katin MJ, Blitzer PH, Rubenstein JH, Galmarini DH, Garton GR et al. Medically Inoperable Lung Carcinoma: The Role of Radiation Therapy. Semin Radiat Oncol 1996;6:98-104.
15. Langendijk H, de Jong J, Tjwa M, Muller M, ten Velde G, Aaronson N et al. External irradiation versus external irradiation plus endobronchial brachytherapy in inoperable non-small cell lung cancer: a prospective randomized study. Radiother Oncol 2001; 58:257-68.
16. Kelly JF, Delclos ME, Morice RC, Huaringa A, Allen PK, Komaki R. High-Dose-Rate endobronchial brachytherapy effectively palliates symptoms due to airway tumors: the 10-years M.D.Anderson Cancer Center experience. Int J Radiat Oncol Biol Phys 2000;48:697-702.
17. Speiser BL, Spratling L. Remote afterloading brachytherapy for the local control of endobronchial carcinoma. Int J Radiat Oncol Biol Phys 1993;25:589-97.
18. Gustafson G, Vincini F, Freedman L. High dose rate endobronchial brachytherapy in the management of primary and recurrent bronchogenic.
19. Nori D, Allison R, Kaplan B. High dose rate intraluminal irradiation in bronchogenic carcinoma. Chest 1993;104:1006-11.
20. Bedwinek J, Petty A, Bruton C. The use of high dose rate endobronchial brachytherapy to palliate symptomatic endobronchial recurrence of previously irradiated bronchogenic carcinoma. Int J Radiat Oncol Biol Phys 1991;22:23-30.
21. Gollins SW, Ryder WDJ, Burt PV. Massive haemoptysis death and other morbidity associated with high dose rate intraluminal radiotherapy for carcinoma of the bronchus. Radiother Oncol 1996;39:105-16